An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery

References

• Santra TS, and Mohan L, editors. Metallic Nanoparticles for Biomedical Applications. In: Nanomaterials and their biomedical applications. Vol. 16. Singapore: Springer Singapore; 2021. p. 29–82.
   Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71.
   PubMed Web of Science ®Google Scholar
• Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79.
   PubMed Web of Science ®Google Scholar
• Tewabe A, Abate A, Tamrie M, et al. Targeted drug delivery — from magic bullet to nanomedicine: principles, challenges, and future perspectives. J Multidiscip Healthc. 2021;14:1711–1724.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Wan J, Zhou L, et al. Stimuli-Responsive nanotherapeutics for precision drug delivery and cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(1). DOI:https://doi.org/10.1002/wnan.1527
   Web of Science ®Google Scholar
• Choi G, Rejinold NS, Piao H, et al. Inorganic–inorganic nanohybrids for drug delivery, imaging and photo-therapy: recent developments and future scope. Chem Sci. 2021;12(14):5044–5063.
   PubMed Web of Science ®Google Scholar
• Mirza S, Ahmad MS, and Shah MIA, et al. magnetic nanoparticles: drug delivery and bioimaging applications. In : Shah MR, Imran M, and Ullah S editors. metal nanoparticles for drug delivery and diagnostic applications. Elsevier; 2020. p. 189–213.
   Google Scholar
• Siafaka PI, Okur NÜ, Karantas ID, et al. Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities. Asian J Pharm Sci. 2021;16(1):24–46.
   PubMed Web of Science ®Google Scholar
• Dadfar SM, Roemhild K, Drude NI, et al. iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302–325.
   PubMed Web of Science ®Google Scholar
• Xie L, Jin W, Chen H, et al. Superparamagnetic iron oxide nanoparticles for cancer diagnosis and therapy. J Biomed Nanotechnol. 2019;15(2):215–416.
   PubMed Web of Science ®Google Scholar
• Reimer P, Schuierer G, Balzer T, et al. Application of a superparamagnetic iron oxide (Resovist®) for MR imaging of human cerebral blood volume. Magn Reson Med. 1995;34(5):694–697.
   PubMed Web of Science ®Google Scholar
• Taboada E, Rodríguez E, Roig A, et al. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir. 2007;23(8):4583–4588.
   PubMed Web of Science ®Google Scholar
• Blanco-Andujar C, Walter A, Cotin G, et al. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia. Nanomed. 2016;11(14):1889–1910.
   PubMed Web of Science ®Google Scholar
• Nikazar S, Barani M, Rahdar A, et al. Photo‐ and magnetothermally responsive nanomaterials for therapy, controlled drug delivery and imaging applications. ChemistrySelect. 2020;5(40):12590–12609.
   Web of Science ®Google Scholar
• Lucena GN, Santos CC, Pinto GC, et al. Surface engineering of magnetic nanoparticles for hyperthermia and drug delivery. Med DEVICES Sens. 2020;3(6). https://doi.org/10.1002/mds3.10100
   Google Scholar
• Salmani MM, Hashemian M, Yekta HJ, et al. Synergic effects of magnetic nanoparticles on hyperthermia-based therapy and controlled drug delivery for bone substitute application. J Supercond Nov Magn. 2020;33(9):2809–2820.
   Web of Science ®Google Scholar
• Attia MF, Anton N, Wallyn J, et al. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185–1198.
   PubMed Web of Science ®Google Scholar
• Wu J. The enhanced permeability and retention (epr) effect: the significance of the concept and methods to enhance its application. J Pers Med. 2021;11(8):771.
   PubMed Web of Science ®Google Scholar
• Saw PE, Xu X, Kim S, et al. Biomedical applications of a novel class of high-affinity peptides. Acc Chem Res. 2021;54(18):3576–3592.
   PubMed Web of Science ®Google Scholar
• Stanicki D, Elst LV, Muller RN, et al. Synthesis and processing of magnetic nanoparticles. Curr Opin Chem Eng. 2015;8:7–14.
   Web of Science ®Google Scholar
• Ali A, Zafar H, Zia M, et al. Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl. 2016;9:49–67.
   PubMed Web of Science ®Google Scholar
• Mosayebi J, Kiyasatfar M, Laurent SS. Functionalization, and design of magnetic nanoparticles for theranostic applications. Adv Healthc Mater. 2017;6(23):1700306.
   Web of Science ®Google Scholar
• Suryawanshi PL, Sonawane SH, Bhanvase BA, et al. Synthesis of iron oxide nanoparticles in a continuous flow spiral microreactor and corning® advanced flowTM reactor. Green Process Synth. 2018;7(1). https://doi.org/10.1515/gps-2016-0138
   Google Scholar
• Vangijzegem T, Stanicki D, Panepinto A, et al. Influence of experimental parameters of a continuous flow process on the properties of very small iron oxide nanoparticles (VSION) designed for T1-weighted Magnetic Resonance Imaging (MRI). Nanomaterials. 2020;10(4):757.
   Web of Science ®Google Scholar
• Jiao M, Zeng J, Jing L, et al. Flow synthesis of biocompatible Fe3O4 nanoparticles: insight into the effects of residence time, fluid velocity, and tube reactor dimension on particle size distribution. Chem Mater. 2015;27(4):1299–1305.
   Web of Science ®Google Scholar
• Besenhard MO, LaGrow AP, Famiani S, et al. Continuous production of iron oxide nanoparticles via fast and economical high temperature synthesis. React Chem Eng. 2020;5(8):1474–1483.
   Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Vangijzegem T, Stanicki D, Laurent S. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Expert Opin Drug Deliv. 2019;16(1):69–78.
   PubMed Web of Science ®Google Scholar
• Gholami A, Mousavi SM, and Hashemi SA, et al. Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy Drug. Metab. Rev. . 2020. https://doi.org/10.1080/03602532.2020.1726943
   Google Scholar
• Turiel-Fernández D, Gutiérrez-Romero L, Corte-Rodriguez M, et al. ultrasmall iron oxide nanoparticles cisplatin (IV) prodrug nanoconjugate: ICP-MS based strategies to evaluate the formation and drug delivery capabilities in single cells. Anal Chim Acta. 2021;1159:338356.
   PubMed Web of Science ®Google Scholar
• Hannecart A, Stanicki D, Vander Elst L, et al. Nano-thermometers with thermo-sensitive polymer grafted uspios behaving as positive contrast agents in low-field MRI. Nanoscale. 2015;7(8):3754–3767.
   PubMed Web of Science ®Google Scholar
• Sumitha NS, Prakash P, Nair BN, et al. Degradation-dependent controlled delivery of doxorubicin by glyoxal cross-linked magnetic and porous chitosan microspheres. ACS Omega. 2021;6(33):21472–21484.
   PubMed Web of Science ®Google Scholar
• Szegedi Á, Trendafilova I, Mihály J, et al. New insight on prednisolone polymorphs in mesoporous silica/maghemite nanocomposites. J Drug Deliv Sci Technol. 2020;60:102092.
   Web of Science ®Google Scholar
• Qi H, Liu C, Long L, et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano. 2016;10(3):3323–3333.
   PubMed Web of Science ®Google Scholar
• Zhu K, Deng Z, Liu G, et al. Photoregulated cross-linking of superparamagnetic iron oxide nanoparticle (SPION) loaded hybrid nanovectors with synergistic drug release and magnetic resonance (MR) imaging enhancement. Macromolecules. 2017;50(3):1113–1125.
   Web of Science ®Google Scholar
• Sabouri Z, Labbaf S, Karimzadeh F, et al. Fe3O4 /bioactive glass nanostructure: a promising therapeutic platform for osteosarcoma treatment. Biomed Mater. 2021;16(3):035016.
   Web of Science ®Google Scholar
• Attari E, Nosrati H, Danafar H, et al. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier. J Biomed Mater Res A. 2019;107(11):2492–2500.
   PubMed Web of Science ®Google Scholar
• Peralta ME, Jadhav SA, Magnacca G, et al. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery. J Colloid Interface Sci. 2019;544:198–205.
   PubMed Web of Science ®Google Scholar
• El-Boubbou K, Ali R, Al-Zahrani H, et al. Preparation of Iron Oxide mesoporous magnetic microparticles as novel multidrug carriers for synergistic anticancer therapy and deep tumor penetration. Sci Rep. 2019;9(1):9481.
   PubMed Web of Science ®Google Scholar
• El-Boubbou K, Ali R, Al-Humaid S, et al. Iron Oxide mesoporous magnetic nanostructures with high surface area for enhanced and selective drug delivery to metastatic cancer cells. Pharmaceutics. 2021;13(4):553.
   PubMed Web of Science ®Google Scholar
• El-Boubbou K. Magnetic Iron Oxide nanoparticles as drug carriers: preparation, conjugation and delivery. Nanomed. 2018;13(8):929–952.
   PubMed Web of Science ®Google Scholar
• Huang Y, Mao K, Zhang B, et al. Superparamagnetic Iron Oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Mater Sci Eng C. 2017;70:763–771.
   PubMed Web of Science ®Google Scholar
• Zou Y, Li D, Wang Y, et al. Polyethylenimine nanogels incorporated with ultrasmall iron oxide nanoparticles and doxorubicin for MR imaging-guided chemotherapy of tumors. Bioconjug Chem. 2020;31(3):907–915.
   PubMed Web of Science ®Google Scholar
• Schleich N, Sibret P, Danhier P, et al. Dual anticancer drug/superparamagnetic iron oxide-loaded plga-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharm. 2013;447(1–2):94–101.
   PubMed Web of Science ®Google Scholar
• Quan Q, Xie J, Gao H, et al. HSA coated Iron Oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm. 2011;8(5):1669–1676.
   PubMed Web of Science ®Google Scholar
• Zhao S, Yu X, Qian Y, et al. Multifunctional magnetic Iron Oxide nanoparticles: an advanced platform for cancer theranostics. Theranostics. 2020;10(14):6278–6309.
   PubMed Web of Science ®Google Scholar
• Bulte JWM. Superparamagnetic Iron Oxides as MPI tracers: a primer and review of early applications. Adv Drug Deliv Rev. 2019;138:293–301.
   PubMed Web of Science ®Google Scholar
• Stueber DD, Villanova J, Aponte I, et al. Magnetic Nanoparticles in biology and medicine: past, present, and future trends. Pharmaceutics. 2021;13(7):943.
   PubMed Web of Science ®Google Scholar
• Tay ZW, Chandrasekharan P, Zhou XY, et al. In vivo tracking and quantification of inhaled aerosol using magnetic particle imaging towards inhaled therapeutic monitoring. Theranostics. 2018;8(13):3676–3687.
   PubMed Web of Science ®Google Scholar
• Tomitaka A, Arami H, Huang Z, et al. Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment. Nanoscale. 2018;10(1):184–194.
   Web of Science ®Google Scholar
• Zhu X, Li J, Peng P, et al., Quantitative drug release monitoring in tumors of living subjects by magnetic particle imaging nanocomposite. Nano Lett. 19(10): 6725–6733. 2019.
   PubMed Web of Science ®Google Scholar
• Jia G, Han Y, An Y, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–316.
   PubMed Web of Science ®Google Scholar
• Weng H, Bejjanki NK, Zhang J, et al. TAT peptide-modified cisplatin-loaded iron oxide nanoparticles for reversing cisplatin-resistant nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2019;511(3):597–603.
   PubMed Web of Science ®Google Scholar
• Gao Z, Li Y, You C, et al. Iron Oxide nanocarrier-mediated combination therapy of cisplatin and artemisinin for combating drug resistance through highly increased toxic reactive oxygen species generation. ACS Appl Bio Mater. 2018;1(2):270–280.
   PubMedGoogle Scholar
• Park J, Park S, Kim S, et al. HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy. J Mater Chem B. 2013;1(36):4576.
   PubMed Web of Science ®Google Scholar
• Alsharif NA, Aleisa FA, Liu G, et al. Functionalization of magnetic nanowires for active targeting and enhanced cell-killing efficacy. ACS Appl Bio Mater. 2020;3(8):4789–4797.
   PubMedGoogle Scholar
• Daglioglu C, Okutucu B. Synthesis and characterization of aicar and dox conjugated multifunctional nanoparticles as a platform for synergistic inhibition of cancer cell growth. Bioconjug Chem. 2016;27(4):1098–1111.
   PubMed Web of Science ®Google Scholar
• Zhu JY, Zheng DW, Zhang MK, et al., Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett. 16(9): 5895–5901. 2016.
   PubMed Web of Science ®Google Scholar
• Xue Z, Zhu M, Dong Y, et al. An integrated targeting drug delivery system based on the hybridization of graphdiyne and mofs for visualized cancer therapy. Nanoscale. 2019;11(24):11709–11718.
   PubMed Web of Science ®Google Scholar
• Elbialy NS, Fathy MM, Al-Wafi R, et al. Multifunctional magnetic-gold nanoparticles for efficient combined targeted drug delivery and interstitial photothermal therapy. Int J Pharm. 2019;554:256–263.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez R, Campbell E, Naumov A. Multifunctional graphene oxide/iron oxide nanoparticles for magnetic targeted drug delivery dual magnetic resonance/fluorescence imaging and cancer sensing. PLOS ONE. 2019;14(6):e0217072.
   PubMed Web of Science ®Google Scholar
• Kim HY, Kumar H, Jo MJ, et al. Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal cord injury treatment. Nano Lett. 2018;18(8):4965–4975.
   PubMed Web of Science ®Google Scholar
• Choi GE, Kang MS, Kim YJ, et al. Magnetically responsive drug delivery using doxorubicin and iron oxide nanoparticle-incorporated lipocomplexes. J Nanosci Nanotechnol. 2019;19(2):675–679.
   PubMed Web of Science ®Google Scholar
• Sharif S, Nguyen KT, Bang D, et al. Optimization of field-free point position, gradient field and ferromagnetic polymer ratio for enhanced navigation of magnetically controlled polymer-based microrobots in blood vessel. Micromachines. 2021;12(4):424.
   PubMed Web of Science ®Google Scholar
• Wu Z, Li T, Li J, et al. Turning erythrocytes into functional micromotors. ACS Nano. 2014;8(12):12041–12048.
   PubMed Web of Science ®Google Scholar
• Liang Y, Xie J, Yu J, et al. Recent advances of high performance magnetic iron oxide nanoparticles: controlled synthesis, properties tuning and cancer theranostics. Nano Sel. 2021;2(2):216–250.
   Google Scholar
• Van Durme R, Crevecoeur G, Dupré L, et al. Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery. Drug Deliv. 2021;28(1):63–76.
   PubMed Web of Science ®Google Scholar
• Sun M, Fan X, Meng X, et al., Magnetic biohybrid micromotors with high maneuverability for efficient drug loading and targeted drug delivery. Nanoscale. 11(39): 18382–18392. 2019.
   PubMed Web of Science ®Google Scholar
• Kim D, Lee H, Kwon S, et al. Bilayer hydrogel sheet‐type intraocular microrobot for drug delivery and magnetic nanoparticles retrieval. Adv Healthc Mater. 2020;9(13):2000118.
   Web of Science ®Google Scholar
• Ramos-Docampo MA, Fernández-Medina M, Taipaleenmäki E, et al. Microswimmers with heat delivery capacity for 3D cell spheroid penetration. ACS Nano. 2019;13(10):12192–12205.
   PubMed Web of Science ®Google Scholar
• Zhao W, Odelius K, Edlund U, et al. In situ synthesis of magnetic field-responsive hemicellulose hydrogels for drug delivery. Biomacromolecules. 2015;16(8):2522–2528.
   PubMed Web of Science ®Google Scholar
• Nowak BP, Niehues M, Ravoo BJ. Magneto-responsive hydrogels by self-assembly of low molecular weight peptides and crosslinking with iron oxide nanoparticles. Soft Matter. 2021;17(10):2857–2864.
   PubMed Web of Science ®Google Scholar
• Ayyanaar S, Balachandran C, Bhaskar RC, et al. ROS-responsive chitosan coated magnetic iron oxide nanoparticles as potential vehicles for targeted drug delivery in cancer therapy. Int J Nanomedicine. 2020;15:3333–3346.
   PubMed Web of Science ®Google Scholar
• Ganivada MN, Rao NV, Dinda H, et al. Biodegradable magnetic nanocarrier for stimuli responsive drug release. Macromolecules. 2014;47(8):2703–2711.
   Web of Science ®Google Scholar
• Gawali SL, Barick KC, Shetake NG, et al. PH-labile magnetic nanocarriers for intracellular drug delivery to tumor cells. ACS Omega. 2019;4(7):11728–11736.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang C, Zhang R, et al. Multifunctional magnetized porous silica covered with poly(2-dimethylaminoethyl methacrylate) for PH controllable drug release and magnetic resonance imaging. ACS Appl Nano Mater. 2018;1(9):5027–5034.
   Web of Science ®Google Scholar
• Liu J, Liu W, Zhang K, et al. A magnetic drug delivery system with “OFF–ON” state via specific molecular recognition and conformational changes for precise tumor therapy. Adv Healthc Mater. 2020;9(3):1901316.
   Web of Science ®Google Scholar
• Faridani OR, Abdullayev I, Hagemann-Jensen M, et al. Single-cell sequencing of the small-RNA transcriptome. Nat Biotechnol. 2016;34(12):1264–1266.
   PubMed Web of Science ®Google Scholar
• Stephen ZR, Kievit FM, Veiseh O, et al. Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O 6 -benzylguanine to brain tumors. ACS Nano. 2014;8(10):10383–10395.
   PubMed Web of Science ®Google Scholar
• Chen W, Cheng CA, Zink JI. Spatial, temporal, and dose control of drug delivery using noninvasive magnetic stimulation. ACS Nano. 2019. DOI:https://doi.org/10.1021/acsnano.8b06655
   Google Scholar
• Mai BT, Balakrishnan PB, Barthel MJ, et al. Thermoresponsive iron oxide nanocubes for an effective clinical translation of magnetic hyperthermia and heat-mediated chemotherapy. ACS Appl Mater Interfaces. 2019;11(6):5727–5739.
   PubMed Web of Science ®Google Scholar
• Kubo T, Tachibana K, Naito T, et al. Magnetic field stimuli-sensitive drug release using a magnetic thermal seed coated with thermal-responsive molecularly imprinted polymer. ACS Biomater Sci Eng. 2019;5(2):759–767.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang K, Wang Y, et al. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy. Theranostics. 2020;10(8):3793–3815.
   PubMed Web of Science ®Google Scholar
• Liu T, Yang K, Liu Z. Recent advances in functional nanomaterials for X-Ray triggered cancer therapy. Prog Nat Sci Mater Int. 2020;30(5):567–576.
   Web of Science ®Google Scholar
• Klein S, Sommer A, Distel LVR, et al. Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation. Biochem Biophys Res Commun. 2012;425(2):393–397.
   PubMed Web of Science ®Google Scholar
• Russell E, Dunne V, Russell B, et al. Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells. Radiat Oncol. 2021;16(1). https://doi.org/10.1186/s13014-021-01829-y
   Google Scholar
• Zanganeh S, Hutter G, Spitler R, et al., Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nature Nanotechnology. 11(11): 986–994. 2016.
   PubMed Web of Science ®Google Scholar
• Ma P, Xiao H, Yu C, et al. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett. 2017;17(2):928–937.
   PubMed Web of Science ®Google Scholar
• Yu B, Choi B, Li W, et al. Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nat Commun. 2020;11(1):3637.
   PubMed Web of Science ®Google Scholar
• Akhter MH, Khalilullah H, Gupta M, et al. Impact of protein corona on the biological identity of nanomedicine: understanding the fate of nanomaterials in the biological milieu. Biomedicines. 2021;9(10):1496.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M. The need for improved methodology in protein corona analysis. Nat Commun. 2022;13(1):49.
   PubMedGoogle Scholar
• Frtús A, Smolková B, Uzhytchak M, et al. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: a road from failure to success in clinical applications. J Controlled Release. 2020;328:59–77.
   PubMed Web of Science ®Google Scholar
• Ke PC, Lin S, Parak WJ, et al. A Decade of the Protein Corona. ACS Nano. 2017;11(12):11773–11776.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y, Tang Q, et al. The protein corona and its effects on nanoparticle-based drug delivery systems. Acta Biomater. 2021;129:57–72.
   PubMed Web of Science ®Google Scholar
• Peng Q, Liu J, Zhang T, et al. Digestive enzyme corona formed in the gastrointestinal tract and its impact on epithelial cell uptake of nanoparticles. Biomacromolecules. 2019;20(4):1789–1797.
   PubMed Web of Science ®Google Scholar
• Lunova M, Prokhorov A, Jirsa M, et al. Nanoparticle core stability and surface functionalization drive the mtor signaling pathway in hepatocellular cell lines. Sci Rep. 2017;7(1). DOI:https://doi.org/10.1038/s41598-017-16447-6
   Google Scholar
• Sharifi S, Caracciolo G, Mahmoudi M. Biomolecular corona affects controlled release of drug payloads from nanocarriers. Trends Pharmacol Sci. 2020;41(9):641–652.
   PubMed Web of Science ®Google Scholar
• Hajipour MJ, Aghaverdi H, Serpooshan V, et al. Sex as an important factor in nanomedicine. Nat Commun. 2021;12(1). DOI:https://doi.org/10.1038/s41467-021-23230-9
   Google Scholar
• Serpooshan V, Sheibani S, Pushparaj P, et al. Effect of cell sex on uptake of nanoparticles: the overlooked factor at the nanobio interface. ACS Nano. 2018;12(3):2253–2266.
   PubMed Web of Science ®Google Scholar
• Debayle M, Balloul E, Dembele F, et al. Zwitterionic polymer ligands: an ideal surface coating to totally suppress protein-nanoparticle corona formation? Biomaterials. 2019;219:119357.
   PubMed Web of Science ®Google Scholar
• Kannan D, Yadav N, Ahmad S, et al. Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite. EBioMedicine. 2019;45:261–277.
   PubMed Web of Science ®Google Scholar
• Qin T, Ma R, Yin Y, et al. Catalytic inactivation of influenza virus by iron oxide nanozyme. Theranostics. 2019;9(23):6920–6935.
   PubMed Web of Science ®Google Scholar
• Miranda MS, Rodrigues MT, Domingues RMA, et al. Development of inhalable superparamagnetic iron oxide nanoparticles (SPIONs) in microparticulate system for antituberculosis drug delivery. Adv Healthc Mater. 2018;7(15):1800124.
   Web of Science ®Google Scholar
• Armijo LM, Wawrzyniec SJ, Kopciuch M, et al. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against pseudomonas aeruginosa biofilms. J Nanobiotechnology. 2020;18(1):35.
   PubMed Web of Science ®Google Scholar
• Narum SM, Le T, and Le DP, et al. Passive targeting in nanomedicine: fundamental concepts, body interactions, and clinical potential. In: Chung EJ, Leon L, and Rinaldi C, editors. Nanoparticles for biomedical applications Elsevier; 2020. p 37–53. DOI: https://doi.org/10.1016/B978-0-12-816662-8.00004-7
   Google Scholar
• Sindhwani S, Syed AM, Ngai J, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566–575.
   PubMed Web of Science ®Google Scholar
• Aw MS, Paniwnyk L, Losic D. The progressive role of acoustic cavitation for non-invasive therapies, contrast imaging and blood-tumor permeability enhancement. Expert Opin Drug Deliv. 2016;13(10):1383–1396.
   PubMed Web of Science ®Google Scholar
• Snipstad S, Hanstad S, Bjørkøy A, et al. Sonoporation using nanoparticle-loaded microbubbles increases cellular uptake of nanoparticles compared to Co-incubation of nanoparticles and microbubbles. Pharmaceutics. 2021;13(5):640.
   PubMed Web of Science ®Google Scholar
• Fang J, Islam W, Maeda H. Exploiting the dynamics of the epr effect and strategies to improve the therapeutic effects of nanomedicines by using epr effect enhancers. Adv Drug Deliv Rev. 2020;157:142–160.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li M, Dey R, et al. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14(1):85.
   PubMed Web of Science ®Google Scholar
• Truong NP, Whittaker MR, Mak CW, et al. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv. 2015;12(1):129–142.
   PubMed Web of Science ®Google Scholar